Drug glucuronidation by human renal UDP-glucuronosyltransferases

Biochemical Pharmacology

Volumn 55, Issue 7, 1998, Pages 1005-1012

  McGurk, Karen A ^a   Brierley, Catherine H ^a   Burchell, Brian ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Biotransformation; Glucuronidation; Human; Kidney; Propofol; Xenobiotic

Indexed keywords

BILIRUBIN; EMODIN; ESTRIOL; FLURBIPROFEN; GALLIC ACID DERIVATIVE; GALLIC ACID OCTYL ESTER; GLUCURONOSYLTRANSFERASE; HYMECROMONE; HYODEOXYCHOLIC ACID; IBUPROFEN; ISOENZYME; KETOPROFEN; LUBROL; MEFENAMIC ACID; NAPROXEN; PROPOFOL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG TRANSFORMATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ISOLATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY; KIDNEY CARCINOMA; KIDNEY MICROSOME; LIVER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TISSUE SPECIFICITY;

BILIRUBIN; BLOTTING, WESTERN; CHROMATOGRAPHY, THIN LAYER; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HUMANS; KIDNEY; MICROSOMES; PHARMACEUTICAL PREPARATIONS; XENOBIOTICS;

EID: 0032055273     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00534-0     Document Type: Article

References (45)

1. Sipes I.G., Gandolfi A.J. Biotransformation of toxicants. Casarett L.J., et al. The Basic Science of Poisins. 1991;88-126 Pergamon Press, Oxford.
2. Mulder G.J., Coughtrie M.W.H., Burchell B. Glucuronidation. Mulder G.J. Conjugation Reactions in Drug Metabolism. 1990;51-105 Taylor Francis, London.
3. Miners J.O., MacKenzie P.I. Drug glucuronidation in humans. Pharmac Ther. 51:1991;347-369.
4. Burchell B, McGurk K, Brierley, CH and Clarke DJ, UDP-Glucuronosyltransferases. In: Biotransformation (Ed. Guengerich FP), pp. 401-435, Vol. 3 Comprehensive Toxicology (Eds. Sipes IG, McQueen CA and Gandolfi AJ) Elsevier Science, Oxford, 1997.
5. Burchell B. Turning on and turning off the sense of smell. Nature. 350:1991;16-17.
6. Lazard D., Zupko K., Poira Y., Nef P., Lazarovits J., Horn S., Khen M., Lancet D. Odorant signal termination by olfactory UDP-glucuronosyltransferases. Nature. 349:1991;790-793.
7. Guyton A.C. Textbook of Medical Physiology. 1981;WB Saunders Company, London.
8. Anders M.W. Metabolism of drugs by the kidney. Kidney Int. 18:1980;636-647.
9. Rush G.F., Newton J.F., Hook J.B. Sex differences in the excretion of glucuronide conjugates the role of intrarenal glucuronidation . J Pharmacol Exp Ther. 227:1983;658-662.
10. Redegeld F.A., Hofman G.A., Noordhoek J. Conjugative clearance of 1-naphthol and disposition of its glucuronide and sulphate conjugates in the isolated perfused rat kidney. J Pharmacol Exp Ther. 244:1988;263-267.
11. Burchell B., Coughtrie M.W.H. UDP-glucuronosyltransferases. Pharmacol Ther. 43:1989;261-289.
12. Foliot A., Drocourt J.L., Etienne J.P., Housset E., Fiessinger J.N., Christoforov B. Increase in hepatic glucuronidation and clearance of bilirubin in clofibrate-treated rats. Biochem Pharmacol. 26:1977;547-549.
13. Coughtrie M.W., Burchell B., Bend J.R. Purification and properties of rat kidney UDP-glucuronosyltransferase. Biochem Pharmacol. 36:1987;245-251.
14. Sutherland L., Ebner T., Burchell B. The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochem Pharmacol. 45:1993;295-301.
15. Burchell B., Coughtrie M.W.H. UDP-glucuronosyltransferases. Kalow W. Pharmacogenetics of Drug Metabolism. 1992;195-225 Pergamon Press, Oxford.
16. Burchell B., Coughtrie M., Jackson M., Harding D., Fournel-Gigleux S., Leakey J., Hume R. Development of human liver UDP-glucuronosyltransferases. Dev Pharmacol Ther. 13:1989;70-77.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
18. 14C]glucuronic acid. Anal Biochem. 109:1980;321-329.
19. Faed E.M. Properties of acyl glucuronides implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev. 15:1984;1213-1249.
20. Spahn L.H., Benet L.Z. Acyl glucuronides revisited is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab Rev. 24:1992;5-47.
21. Spahn L.H., Benet L.Z. Microsomal acyl glucuronidation enzyme-kinetic studies with labile glucuronides . Pharmacology. 46:1993;268-273.
22. Heirwegh K.P.M., Van der Vijver M., Fevery J. Assay and properties of digitonin-activated bilirubin uridine diphosphate glucuronosyltransferase from rat liver. Biochem J. 129:1972;605-608.
23. Senafi S.B., Clarke D.J., Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase UDP sugar specificity and involvement in steroid and xenobiotic glucuronidation . Biochem J. 303:1994;233-240.
24. Sutherland L., Senafi S.B., Ebner T., Clarke D.J., Burchell B. Characterisation of a human bilirubin UDP-glucuronosyltransferase stably expressed in hamster lung fibroblast cell cultures. FEBS Lett. 308:1992;161-164.
25. Otani G., Abou-El-Makarem M.M., Bock K.W. UDP-glucuronosyltransferase in perfused rat liver and in microsomes. III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin. Biochem Pharmacol. 25:1976;1293-1297.
26. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets procedure and some applications . Proc Natl Acad Sci USA. 76:1979;4350-4354.
28. Jackson M.R., Kennedy S.M.E., Lown G., Burchell B. Induction of UDP-glucuronosyltransferase mRNA in embryonic chick livers by phenobarbital. Biochem Pharmacol. 35:1986;1191-1198.
29. Banhegyi G., Garzo T., Fulceri R., Benedetti A., Mandl J. Latency is the major determinant of UDP-glucuronosyltransferase activity in isolated hepatocytes. FEBS Lett. 328:1993;149-153.
30. Graham A.B., Wood G.C. Factors affecting the response of microsomal UDP-glucuronosyltransferase to membrane perturbants. Biochem Biophys Acta. 311:1973;45-50.
31. Ebner T., Burchell B. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos. 21:1993;50-55.
32. Sallustio B.C., Purdie Y.J., Birkett D.J., Meffin P.J. Effect of renal dysfunction on the individual components of the acyl-glucuronide futile cycle. J Pharmacol Exp Ther. 251:1989;288-294.
33. Vree T.B., Hekster Y.A., Anderson P.G. Contribution of the human kidney to the metabolic clearance of drugs. Ann Pharmacother. 26:1992;1421-1428.
34. Litterst C.L., Mimnaugh E.G., Gram T.E. Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity. Biochem Pharmacol. 26:1977;749-755.
35. Diamond G.L., Anders M.W., Tremaine L.M., Quebbemann A.J. Salicylate enhancement of renal glucuronide conjugation and tubular excretory transfer of phenols. Drug Metab Dispos. 10:1982;573-578.
36. Hanninen O., Aitio A. Enhanced glucuronide formation in different tissues following drug administration. Biochem Pharmacol. 17:1968;2307-2311.
37. Munzel P.A., Bruck M., Bock K.W. Tissue specific consitutive and inducible expression of rat phenol UDP-glucuronsyltransferase. Biochem Pharmacol. 47:1994;1445-1448.
38. Harding D., Fournel-Gigleux S., Jackson M.R., Burchell B. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in Cos-7 cells. Proc Natl Acad Sci USA. 85:1988;8381-8385.
39. Ritter J.K., Chen F., Sheen Y.Y., Lubet R.A., Owens I.S. Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry. 31:1992;3409-3414.
40. Jin C., Miners J.O., Lillywhite K.J., Mackenzie P.I. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther. 264:1993;475-479.
41. Jackson M.R., McCarthy L.R., Harding D., Wilson S., Coughtrie M.H.W., Burchell B. Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. Biochem J. 242:1987;581-588.
42. Pillot T., Ouzzine M., Fournel-Gigleux S., Lafaurie C., Radominska A., Burchell B., Siest G., Magdalou J. Glucuronidation of hyodeoxycholic acid in human liver. J Biol Chem. 268:1993;25636-25642.
43. Wooster R., Sutherland L., Ebner T.E., Clarke D., Da Cruz O., Burchell B. Cloning and stable expression of a new member of the human liver phenol/bilirubin UDP-glucuronsyltransferase cDNA family . Biochem J. 278:1991;465-469.
44. Raoff A.A., van-Obbergh L.J., de Ville de Goyet J., Verbeeck R.K. Extrahepatic glucuronidation of propofol in man possible contribution of gut wall and kidney . Eur J Clin Pharmacol. 50:1996;91-96.
45. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Roy Chowdhury J., Ritter J.K., Schachter H., Tephly T., Tipton K.F., Nerbert D. The UDP glycosyltransferases gene superfamily recommended nomenclature update based on evolutionary divergence . Pharmacogenetics. 7:1997;225-269.